HIV Care Grant Program Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Awards
Grant Amount: For the Limited New Competition, approximately $10 million is expected to be available in Federal fiscal year 2013; for the Competing Continuation, approximately $65 million is expected to be available in Federal fiscal year 2013.
This announcement solicits applications for the Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funding (ERF), which enables the Secretary to utilize resources to control epidemics of any disease. ADAP is administered by the Health Resources and Services Administration’s (HRSA) HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP).
(1) Limited New Competing ADAP ERF grant awards are intended for States/Territories that can demonstrate the need for additional resources to address “cost-cutting” and/or “cost-saving” measures instituted from the date of issuance of the last ADAP ERF FOA on May 2, 2012 to April 30, 2013, and States that have implemented a waiting list as of January 1, 2013. Limited new competing ADAP ERF awards will be based on the applicant’s ability to successfully demonstrate need for the additional funding and the success of the State’s past efforts to improve the cost-effectiveness of ADAP operations consistent with HRSA recommendations and policies and to maximize available resources. This determination will be made by an external Objective Review Committee (ORC) based on their review and scoring of applicant’s responses to criteria published in this funding opportunity announcement, with priority given to addressing waiting lists.
Important Note: • States with an ADAP waiting list reported to HRSA as of January 1, 2013 must use all funding awarded under this announcement to remove clients from the waiting list. • States that did not report a waiting list to HRSA as of January 1, 2013, must use funding awarded under this announcement to address “cost-cutting” measures (e.g. reduction in ADAP eligibility below 300% FPL and/or the formulary with respect to antiretroviral and drugs to treat opportunistic infections or HIV/AIDS complications) and/or support the implementation of “cost-saving” measures during the project period to prevent a waiting list.
(2) Competing Continuation ADAP ERF grants are intended to provide support to Ryan White Part B grantees that received fiscal year (FY) 2012 ERF, to the extent that the grantee provides adequate justification for additional funding. A total of $65 million is available for FY 2013 competing continuation awards. Funds will be awarded on a needs-based formula. Competing continuation awards are intended to: • Prevent, reduce and/ or eliminate ADAP waiting lists that were reported to HRSA. • Address “cost-cutting” measures initiated after September 30, 2012 and/or complete the implementation of “cost saving” measures initiated after September 30, 2012.
Applicants are advised that competing continuation awards: • Will be capped at the applicant’s FY 2012 ADAP ERF award amount; • Are not guaranteed, but rather will be determined by the applicant’s documentation and justification of the need for continuation funds for the 6-month project and budget period (September 30, 2012 – March 31, 2014).
US Department of Health and Human Services Public Health Service Health Resources and Services Administration
Number of Awards Given
Total up to 35 grantees
Award Amount Notes
For the Limited New Competition, approximately $10 million is expected to be available to fund 10 grantees. Applicants may apply for a ceiling amount of up to $3 million per year. The project period is six months. For the Competing Continuation, approximately $65 million is expected to be available to fund up to 25 grantees. Applicants for the competing continuation funding may apply for a ceiling amount of their total FY 2012 ADAP ERF award.
This funding opportunity announcement is subject to availability of appropriated funds. If associated funding is not available for the Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Awards, this announcement will be withdrawn and grants will not be awarded.
Application Due Date
Grants.gov Contact Center , Phone: (800) 518-4726
Heather Hauck Director Div of State HIV/AIDS ProgramsHIV/AIDS Bureau Parklawn Building, Room 7A-15 5600 Fishers Lane Rockville, MD 20857 Phone: (301) 443-6745 Fax: (301) 443-8143
Financial Services to Individuals HIV/AIDS Prevention Medical Treatments and Therapies
Low Income Persons Persons with HIV/AIDS
HRSA requires applicants for this funding opportunity announcement to apply electronically through Grants.gov. The registration and application process protects applicants against fraud and ensures that only authorized representatives from an organization can submit an application. Applicants are responsible for maintaining these registrations, which should be completed well in advance of submitting an application. All applicants must submit in this manner unless they obtain a written exemption from this requirement in advance by the Director of HRSA’s Division of Grants Policy. Applicants must request an exemption in writing from DGPWaivers@hrsa.gov, and provide details as to why they are technologically unable to submit electronically through the Grants.gov portal. If requesting a waiver, include the following in the e-mail request: the HRSA announcement number for which the organization is seeking relief, the organization’s DUNS number, the name, address, and telephone number of the organization and the name and telephone number of the Project Director as well as the Grants.gov Tracking Number (GRANTXXXX) assigned to the submission along with a copy of the “Rejected with Errors” notification as received from Grants.gov. HRSA’s Division of Grants Policy is the only office authorized to grant waivers. HRSA and its Digital Services Operation (DSO) will only accept paper applications from applicants that received prior written approval. However, the application must still be submitted by the deadline. Suggestion: ubmit application to Grants.gov at least two days before the deadline to allow for any unforeseen circumstances.
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.